Unknown

Dataset Information

0

Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.


ABSTRACT: The cytoplasmic pattern recognition receptor RIG-I is activated by viral RNA and induces type I IFN responses to control viral replication. The cellular dsRNA binding protein PACT can also activate RIG-I. To counteract innate antiviral responses, some viruses, including Ebola virus (EBOV), encode proteins that antagonize RIG-I signaling. Here, we show that EBOV VP35 inhibits PACT-induced RIG-I ATPase activity in a dose-dependent manner. The interaction of PACT with RIG-I is disrupted by wild-type VP35, but not by VP35 mutants that are unable to bind PACT. In addition, PACT-VP35 interaction impairs the association between VP35 and the viral polymerase, thereby diminishing viral RNA synthesis and modulating EBOV replication. PACT-deficient cells are defective in IFN induction and are insensitive to VP35 function. These data support a model in which the VP35-PACT interaction is mutually antagonistic and plays a fundamental role in determining the outcome of EBOV infection.

SUBMITTER: Luthra P 

PROVIDER: S-EPMC3875338 | biostudies-literature | 2013 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.

Luthra Priya P   Ramanan Parameshwaran P   Mire Chad E CE   Weisend Carla C   Tsuda Yoshimi Y   Yen Benjamin B   Liu Gai G   Leung Daisy W DW   Geisbert Thomas W TW   Ebihara Hideki H   Amarasinghe Gaya K GK   Basler Christopher F CF  

Cell host & microbe 20130701 1


The cytoplasmic pattern recognition receptor RIG-I is activated by viral RNA and induces type I IFN responses to control viral replication. The cellular dsRNA binding protein PACT can also activate RIG-I. To counteract innate antiviral responses, some viruses, including Ebola virus (EBOV), encode proteins that antagonize RIG-I signaling. Here, we show that EBOV VP35 inhibits PACT-induced RIG-I ATPase activity in a dose-dependent manner. The interaction of PACT with RIG-I is disrupted by wild-typ  ...[more]

Similar Datasets

| S-EPMC2872155 | biostudies-literature
| S-EPMC1426423 | biostudies-literature
| S-EPMC3909728 | biostudies-literature
| S-EPMC2626716 | biostudies-literature
| S-EPMC6582406 | biostudies-literature
| S-EPMC8005759 | biostudies-literature
| S-EPMC1894824 | biostudies-literature
| S-EPMC4403485 | biostudies-literature
| S-EPMC4500542 | biostudies-literature